Zydus Lifesciences Ltd
₹1188.10
-52.50 (4.23%)
Sat, 07 Nov 2026, 11:21 pm
Zydus Lifesciences News
Zydus Saroglitazar shows promise in MASH trial
Zydus Therapeutics reported Phase 2b data showing 39.1% steatohepatitis resolution with 4mg saroglitazar vs 13.7% placebo in MASH patients with fibrosis.
06 Nov 2026
companies
LIC cuts Zydus Lifesciences stake to 3.184%
Life Insurance Corporation of India reduced its holding in Zydus Lifesciences Ltd to 3.184% after selling 20,242,068 shares in the open market between August 2025 and November 2026.
06 Nov 2026
companies
Zydus to join Avendus Spark conference
Zydus Lifesciences will participate in the Avendus Spark Investor Conference in Mumbai on November 17, 2026. The company filed this disclosure with BSE and NSE.
05 Nov 2026
companies
Zydus Lifesciences to attend JM Financial conference
Zydus Lifesciences will participate in the JM Financial 17th Annual Flagship Conference in Mumbai on November 18, 2026.
05 Nov 2026
companies
Zydus appoints Walker Chandiok as auditor
Zydus Lifesciences Ltd has appointed Walker Chandiok & Co LLP as statutory auditors for a 5-year term starting FY27, replacing Deloitte under mandatory rotation rules.
04 Nov 2026
companies
Market Current News
Amber Enterprises India Limite
Amber subsidiary files DRHP for IPO
Amber Enterprises' material subsidiary IL JIN Electronics filed its DRHP with SEBI on November 7, 2026, for a proposed initial public offering.
07 Nov 2026
ipo
Dhanteras gold and silver sales volume seen up 20-30%
Gold and silver sales volumes on Dhanteras are expected to rise 20-30%, driven by a significant drop in precious metal prices, with silver demand leading the increase.
06 Nov 2026
commodities
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo